4Mitsuoka H, Schmid -Schonbein G W. Mechanisms for blockade ofin vivo activator production in the ischemic intestine and multi - or-gan failure. Shock, 2000,14(5):522-527.
5Gennari R, Alexander J W, Boyce S T, et al. Effects of the an-giotensin converting enzyme inhibitor enalapril on bacterial translo-cation after thermal injury and bacterial challenge. Shock, 1996, 6(2):95-100.
6Krack A, Sharma R,Figulla H R, et al. The importance of the gas-trointestinal system in the pathogenesis of heart failure. Eur Heart J,2005,26(22):2368-2374.
7Stumpf C,Lehner C,Yilmaz A, et al. Decrease of serum levels ofthe antiinflammatory cytokine inter leukin -10 in patients with ad-vanced chronic heart failure. Clin Sci (Lond),2003,105(1):45-50.
9Sharma R, von Haehling S, Rauchhaus M, et al. Whole blood en-dotoxin responsiveness in patients with chronic heart failure: theimportance of serum lipoproteins. Eur J Heart Fail, 2005, 7(4):479 -484.
